These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29934414)

  • 41. Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees.
    Mohr ALA; Friscia M; Yeakel JK; Logan BK
    Forensic Sci Int; 2018 Jan; 282():168-178. PubMed ID: 29216523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The medicine and drug-abusing patient].
    Sjøgren P; Rindom H
    Ugeskr Laeger; 2006 Dec; 168(49):4317-9. PubMed ID: 17164063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
    Soussan C; Kjellgren A
    Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New/emerging psychoactive substances and associated psychopathological consequences.
    Schifano F; Napoletano F; Chiappini S; Guirguis A; Corkery JM; Bonaccorso S; Ricciardi A; Scherbaum N; Vento A
    Psychol Med; 2021 Jan; 51(1):30-42. PubMed ID: 31327332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.
    Deen AA; Claridge H; Treble RD; Hamnett HJ; Copeland CS
    J Psychopharmacol; 2021 Nov; 35(11):1315-1323. PubMed ID: 34182812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Classical and novel psychoactive substances: rethinking drug misuse from an evolutionary psychiatric perspective.
    St John-Smith P; McQueen D; Edwards L; Schifano F
    Hum Psychopharmacol; 2013 Jul; 28(4):394-401. PubMed ID: 23881888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Baths salts, spice, and related designer drugs: the science behind the headlines.
    Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
    J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics.
    Meyer MR
    Arch Toxicol; 2016 Oct; 90(10):2421-44. PubMed ID: 27665567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act.
    Webb NE; Wood DM; Greene SL; Hunter LJ; Archer JRH; Dines AM; Dargan PI
    Clin Toxicol (Phila); 2019 Jan; 57(1):36-41. PubMed ID: 30067112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).
    Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Sedefov R; Dargan PI;
    Clin Toxicol (Phila); 2015 Nov; 53(9):893-900. PubMed ID: 26503789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. From concept(ion) to life after death/the grave: The 'natural' history and life cycle(s) of novel psychoactive substances (NPS).
    Corkery JM; Orsolini L; Papanti D; Schifano F
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analytical evidence to show letters impregnated with novel psychoactive substances are a means of getting drugs to inmates within the UK prison service.
    Ford LT; Berg JD
    Ann Clin Biochem; 2018 Nov; 55(6):673-678. PubMed ID: 29534614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.
    Smith KE; Bunting AM; Staton M; Walker R; Shalash S; Winston E; Pangburn K
    J Psychoactive Drugs; 2017; 49(5):436-445. PubMed ID: 28813207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital.
    Tanti M; Cosgrove J; Kelleher C; Jones R; Maguire M
    Clin Med (Lond); 2021 May; 21(3):189-194. PubMed ID: 33947659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.
    Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA
    Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
    Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
    Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The risk of violence associated with novel psychoactive substance misuse in patients presenting to acute mental health services.
    Shafi A; Gallagher P; Stewart N; Martinotti G; Corazza O
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.
    Mohr ALA; Logan BK; Fogarty MF; Krotulski AJ; Papsun DM; Kacinko SL; Huestis MA; Ropero-Miller JD
    J Anal Toxicol; 2022 Jul; 46(6):e116-e185. PubMed ID: 35445267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel psychoactive substance and other drug use by young adults in Western australia.
    Goggin LS; Gately N; Bridle RI
    J Psychoactive Drugs; 2015; 47(2):140-8. PubMed ID: 25950594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.